Our Technology

The ReFlow® Mini Flusher

The only noninvasive device designed to restore, increase, or maintain cerebrospinal fluid flow within a shunt system, post-operative.

Transparent plastic inline switch with two connected cables on a white background.
Pediatric & Adult
Suitable for all ages
30M
Patients worldwide with hydrocephalus¹
50%
Shunt failure within 2 years historically²
$40k
Cost per revision surgery³
FDA
Cleared

Proximal catheter failure is the most common complication in hydrocephalus shunt treatment⁴

Medical professional with patient

Hydrocephalus affects over 30 million people worldwide

The standard treatment, a surgically implanted shunt, drains excess cerebrospinal fluid from the brain to relieve pressure.

But shunts are fragile. Up to 50% of shunts in the pediatric population fail within the first year⁵, primarily due to occlusion, blockages caused by tissue, blood or debris clogging the ventricular catheter's flow holes.

When a shunt fails, it requires revision surgery. Each revision costs upwards of $40,000 and carries its own risks. Some patients endure dozens of surgeries across their lifetime.

Until now, there has been no device to maintain catheter flow without going back into the operating room.

1 Stony Brook Medicine. New Research Reconsiders the Cause of Hydrocephalus. news.stonybrookmedicine.edu/news/new-research-reconsiders-the-cause-of-hydrocephalus

2 Hydrocephalus Association. Complications of Shunt Systems. hydroassoc.org/complications-of-shunt-systems/

3 Cureus. 2024 Jun 13;16(6):e62334. doi:10.7759/cureus.62334

4 J Neurosurg Pediatr. 2024 Apr 12;34(1):84–93. doi:10.3171/2024.2.PEDS23356

5 Azzam et al. 2021;12:419.

How ReFlow Works

Female doctor with stethoscope smiling and consulting with seated female patient in a medical office.

Attached to the shunt system.

The ReFlow® Mini Flusher is placed in-line between the ventricular catheter and the shunt valve during a standard implant or revision procedure. It does not significantly alter the surgical technique or add meaningful time.

Passive to normal flow.

When ReFlow is not pressed, the device is completely passive with bidirectional flow possible. CSF flows freely through the flusher to be regulated by the shunt valve.

A controlled flush on demand.

A deliberate press of the flusher dome sends less than half a milliliter of fluid toward the ventricular catheter, clearing inlet flow holes and restoring CSF flow. No surgery. No hospital visit.

ReFlow Mini Flusher device with finger pressing dome

Engineered to work with the shunt system you already trust

The ReFlow® Mini Flusher works with shunt valves, ventricular catheters, and distal catheters of most makes and models. It connects directly to the shunt ventricular catheter on one side and a pressure-controlled valve on the other.

All components are implanted under the scalp. The device is designed to support a broad patient population, from infants to older adults.

Medical professional with patient

Universal compatibility

Works with most commercially available shunt systems

Elderly man kisses smiling elderly woman as they hold coffee mugs in a cozy kitchen.
Smiling mother and father embrace their young child outdoors in golden sunlight.

Minimal surgical impact

Does not significantly alter implant technique or add time

Scalable across populations

Designed for infants through elderly patients

Happy elderly couple dancing together inside a cozy home, smiling and holding hands.

Retrograde Flow

When depressed, ReFlow sends a flush of CSF back down the ventricular catheter to clear inlet holes.

Two breakthroughs.
One technology.

ReFlow® is the only noninvasive flushing technology to earn FDA Breakthrough Device Designation twice, across both the Mini Flusher and the EVD Flusher.

2021 Breakthrough

Granted for ReFlow Mini Flusher for the breakthrough method of clearing proximal catheter occlusion non-invasively, a complication that drives up to 80% of shunt revision surgeries.

FDA Breakthrough Device Designation, 2021.

ReFlow Mini Flusher close-up

2025 Breakthrough

The FDA has granted Breakthrough Device Designation to the ReFlow EVD Flusher, recognizing its potential to improve the management of patients requiring external ventricular drainage.

FDA Breakthrough Device Designation, 2025.

ReFlow ventricular catheter
FDA Cleared·ReFlow Mini Available Now·35+ Centers
Curved light streaks in blue, purple, and orange on a white background.

Proven outcomes. Published data.
Real patients.

The first-generation ReFlow device has been implanted in patients with hydrocephalus across 35+ leading US neurosurgical centers, with up to six years of clinical follow-up.

In a peer-reviewed study of 9 patients who experienced 14 proximal shunt failures in the two years before ReFlow implantation, only 1 proximal failure occurred in the 2–4 years following implantation and use of ReFlow for flow maintenance.

6+ years
Of clinical follow-up data
11
Clinical studies and reports
2
Generations of product development: ReFlow and ReFlow Mini
35+
Centers with patients implanted across the US

Real-world use cases, visualized.

Ultrasound Visualization of Flush through Burr-Hole Sonolucent Plate

Middle-Aged Male Adult (Gen 2)

Idiopathic Intracranial Hypertension (IIH)

  • Persistent headache at 4 & 10-week follow-up
  • Ultrasound performed during ReFlow flush
  • Septal bowing to the contralateral side & tissue deformation observed during flush
  • Proximal catheter patency confirmed
  • Flushing well-tolerated, no complications

Lee R, Meggyesy M, Ahn J, Theodore J, Biswas D, Luciano M. Trans-burr hole ultrasound to confirm ReFlow System Mini function and proximal catheter patency in a hydrocephalus patient with a ventricular shunt [abstract]. ISHCSF Meeting; 1316 September 2024, Nagoya, Japan.

Acute ReFlow Intervention Visualized with Ultrasound Intraoperatively

5-Year-Old Male (Gen 1)

Hydrocephalus from post-AVM rupture hemorrhage

  • At shunt placement completion with ReFlow in-line, the shunt reservoir was noted not to refill
  • Following non-invasive manual depression of ReFlow, intraoperative ultrasound demonstrated debris clearing from the obstructed ventricular catheter
  • CSF flow returned, followed by brisk refill of shunt valve

Porter Z, Yang G, Vuong S, Hanna B, Madsen J, Vadivelu S. In situ clearance of a proximal shunt malfunction in a child with hydrocephalus post cerebral arteriovenous malformation rupture noted intraoperatively. Surg Neurol Int. 2020 May 16;11:116. doi:10.25259/SNI_156_2020.